Please use this identifier to cite or link to this item:
https://wslhd.intersearch.com.au/wslhdjspui/handle/1/8353
Title: | Are we done with hydroxychloroquine for COVID-19? Studies with ethical, legal, and methodological concerns must now be retracted |
Authors: | Frank, F.;Barriere, J.;Gorski, D.;Lemaitre, F.;Meyerowitz-Katz, Gideon;Mulot, M.;Samuel, A.;Zureik, M.;Besan?on, L. |
WSLHD Author: | Meyerowitz-Katz, Gideon |
Subjects: | Infections |
Issue Date: | 2023 |
Citation: | 2023 |
URI: | https://wslhd.intersearch.com.au/wslhdjspui/handle/1/8353 |
Type: | Journal Article |
Study or Trial: | Comment |
Department: | Diabetes and Endocrinology |
Facility: | Blacktown Westmead |
Affiliated Organisations: | Medical Oncology Department, Polyclinique Saint-Jean, Cagnes-sur-Mer, France Ilitch Department of Surgery, Wayne State University School of Medicine, Detroit, MI, USA Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Center, Detroit, MI, USA Pharmacology Departrnent, H?pital Pontchaillou, Univ Rennes, CHU de Rennes, Inserm, EHESP, Irset (Institut de Recherche en Sant?, Environnement et Travail)-UMR S 1085, 2 rue Henri Le Guilloux, 35033 Rennes Cedex, France INSERM. Centre d'Investigation Clinique 1414, Rennes, France School of Health and Society, University of Wollongong, Wollongong, Australia University of Versailles Saint-Quentin-en-Yvelines Media and Information Technology, Link?ping University, Norrk?ping, Sweden |
Appears in Collections: | Blacktown Mount Druitt Hospital |
Files in This Item:
There are no files associated with this item.
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.